Up-to-date Haemophilus influenzae type b vaccination coverage during a vaccine shortage

Pediatrics

Volumn 127, Issue 3, 2011, Pages

  White, Karen E ^a   Pabst, Laura J ^b   Cullen, Karen A ^b  

^a MINNESOTA DEPARTMENT OF HEALTH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Haemophilus influenza type b; Immunization information systems; Vaccination coverage

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; CONTROLLED STUDY; DIPHTHERIA; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFANT; INFORMATION PROCESSING; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; TETANUS; UNITED STATES; VACCINATION;

BACTERIAL CAPSULES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; RETROSPECTIVE STUDIES; UNITED STATES; VACCINATION;

EID: 79952226544     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-2129     Document Type: Article

References (20)

1. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older: Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep. 1991;40(RR-1):1-7
2. Centers for Disease Control and Prevention (CDC). Interim recommendations for the use of Haemophilus influenzae type b (Hib) conjugate vaccines related to the recall of certain lots of Hib-containing vaccines (PedvaxHIB and Comvax). MMWR Morb Mortal Wkly Rep. 2007;56(50):1318-1320
3. Centers for Disease Control and Prevention (CDC). Invasive Haemophilus influenzae Type B Disease in Young Children and Importance for All Young Children to Receive 3 Dose Primary Series with Available Hib-containing Vaccine. Atlanta, GA: CDC Health Alert Network. Distributed via Health Alert Network March 18, 2009. Available at: www2a.cdc.gov/HAN/ArchiveSys/ViewMsgV. asp?AlertNum=000281. Accessed March 15, 2010
4. Borgmeyer C. Merck Recalls 1 Million Hib Vaccine Doses. CDC: No Health Threat, Just Headaches for Physicians. Leawood, KS: American Academy of Family Physicians; 2007. Available at: www.aafp.org/online/en/ home/publications/news/ news-now/clinical-care-research/20071213hibvaccinefolo.html. Accessed January 22, 2011
5. American Academy of Pediatrics (AAP). Pediatric practice in action: Hib vaccine recall and new recommendations. In: AAP Immunization Initiatives Newsletter. Elk Grove Village, IL: American Academy of Pediatrics; 2007. Available at: www.aap.org/immunization/pediatricians/ newsletters/December2007- enews.pdf. Accessed January 22, 2010
6. Centers for Disease Control and Prevention (CDC). Invasive. Haemophilus influenzae type B disease in five young children: Minnesota, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(3):58-60
7. Centers for Disease Control and Prevention (CDC). Progress in immunization information systems: United States, 2008. MMWR Morb Mortal Wkly Rep. 2010:59(5):133-135
8. CDC. Q&A About Sentinel Sites. Available at: www.cdc.gov/vaccines/ programs/iis/ activities/sentinel-sites.htm. Accessed February 1, 2011
9. Jackson ML. Surveillance for invasive Haemophilus influenzae type b (Hib) during the Hib vaccine shortage. Presented at the Meeting of the Advisory Committee for Immunization Practices, Atlanta, GA, June 25, 2009. Available at: www.cdc.gov/vaccines/ recs/acip/downloads/mtg-slides-jun09/11-3-hib.pdf. Accesses January 23, 2011
10. Arizona Department of Health Services. Population by five-year age groups, county, gender and race/ethnicity, Arizona, 2008. In: Arizona Vital Statistics: Population Denominators for 2008. Phoenix, AZ: Arizona Department of Health Services; 2009. Available at: www.azdhs.gov/ plan/menu/info/pop/pop08/ pd08.htm. Accessed March 15, 2010
11. Freed GL, Davis MM, Clark SJ. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. JAMA. 2003;289(5):575-578 (Pubitemid 37428629)
12. Kempe A, Babbel C, Wallage GS, et al. Knowledge of interim recommendations and use of Hib vaccine during vaccine shortages. Pediatrics. 2010;125(5):914-920
13. Santoli JM, Peter G, Arvin AM, et al. Strengthening the supply of routinely recommended vaccines in the United States: recommendations from the National Vaccine Advisory Committee. JAMA. 2003;290(23):3122-3128 (Pubitemid 37548118)
14. Klein JO, Myers MG. Vaccine shortages: why they occur and what needs to be done to strengthen vaccine supply. Pediatrics. 2006;117(6):2269-2275 (Pubitemid 46071273)
15. Broder KR, MacNeil A, Malone S, et al. Who's calling the shots? Pediatricians' adherence to the 2001-2003 pneumococcal conjugate vaccine-shortage recommendations. Pediatrics. 2005;115(6):1479-1487
16. Stokley S, Santoli JM, Willis B, Kelley V, Vargas-Rosalas A, Rodewald LE. Impact of vaccine shortages on immunization programs and providers. Am J Prev Med. 2004;26(1):15-21 (Pubitemid 38045168)
17. Fairbrother G, Broder K, Staat MA, et al. Pediatricians' adherence to pneumococcal conjugate vaccine shortage recommendations in 2 national shortages. Pediatrics. 2007;120(2). Available at: www.pediatrics. org/cgi/content/full/ 120/2/e401
18. Zun LS, Downey L. Tetanus immunization shortage in the United States. Am J Emerg Med. 2003;21(4):298-301 (Pubitemid 36959131)
19. Groom H, Bhatt A, Washington ML, Santoli J. Temporary vaccine recommendations and provider compliance: a survey of pediatric practices during the 2003-2004 pneumococcal conjugate vaccine shortage. Pediatrics. 2008;122(4). Available at: www. pediatrics.org/cgi/content/full/122/4/e835
20. Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25